Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline in mild to moderate Alzheimer's disease
NCT02359552Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- May 2015
- Primary completion
- Aug 2018
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of rasagiline in Alzheimer's disease (AD), sponsored by Cleveland Clinic. Started May 2015; status: completed.
02
Drugs
rasagiline
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02359552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359552.